John Barkett, MBA, managing director in Berkeley Research Group’s Healthcare Transactions and Strategy practice, explained that the effects on both people on Medicare and pharmaceutical companies will be minimal for a couple of years until the executive order—signed by the […]
Effects of Executive Order Could Take Years to Appear: John Barkett, MBA Read More »
An article from UnitedHealth Group referenced a study from The American Journal of Managed Care® (AJMC®) published online early on May 9, 2025. The study, “Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare,” found that Medicare Advantage was associated
AJMC® in the Press, May 23, 2025 Read More »
Ali Khawar, former principal deputy assistant secretary with the Employee Benefits Security Administration, US Department of Labor, emphasizes that patients need to be heard when the Trump administration makes a decision about whether the federal rule regarding the Mental Health
Christine Funke, MD, a glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, discussed how minimally invasive glaucoma surgery (MIGS) has been able to offer her patients better quality of life in treating their glaucoma when compared with
John Barkett, MBA, managing director in Berkeley Research Group’s Healthcare Transactions and Strategy practice, reiterated that the executive order that President Donald Trump signed on May 12 to lower drug costs could be met with legal challenges from the drug
Legal Challenges Likely Following Drug Pricing Executive Order: John Barkett, MBA Read More »
Ali Khawar, former principal deputy assistant secretary with the Employee Benefits Security Administration, US Department of Labor, discussed how the federal rule passed in September 2024 regarding the Mental Health Parity and Addiction Equity Act (MHPAEA) was meant to clarify
Federal Rule Aimed to Clarify Equity for Mental Health Coverage: Ali Khawar Read More »
Young adults and adolescents with HIV have increased risk of developing either a sleep disorder or a mental health issue, according to a new review published in BMJ Open.1 This finding emphasizes the need for interventions in this population to
Adolescents, Young Adults With HIV at Increased Risk of Mental Health Issues Read More »
John Barkett, MBA, managing director in Berkeley Research Group’s Healthcare Transactions and Strategy practice, explained how the current executive order, signed by President Donald Trump on May 12, is different than a previous attempt at establishing “most favored nation” pricing
How Trump’s New Drug Pricing EO Differs From Past Attempts: John Barkett, MBA Read More »
John Barkett, MBA, managing director in BRG’s Healthcare Transactions and Strategy practice, detailed how the executive order that was signed by President Donald Trump on May 12 will attempt to impose “most favored nation” pricing for medication in the US.
New Executive Order Aims for Most-Favored Nation Pricing: John Barkett, MBA Read More »
An article from Anthropocene referenced a study to be published in the September 2025 issue of The American Journal of Managed Care® (AJMC®) and published online on April 22, 2025. The study, “Impact of Telemedicine Use on Outpatient-Related CO2 Emissions:
AJMC® in the Press, May 16, 2025 Read More »
